Bryan Johnson Diagnosed with Autoimmune Gastritis, Vows to Solve It

Bryan Johnson, the 48-year-old biotech entrepreneur who became famous for his extreme anti-aging efforts, just dropped some surprising news: he’s been diagnosed with autoimmune gastritis, a condition where his own immune system attacks his stomach lining. Rather than treating this as a setback, Johnson is predictably framing it as an opportunity.

“My stomach is eating itself,” Johnson announced on Instagram this week, “and here is why that makes me excited.” Only someone deeply invested in the longevity movement could spin an incurable autoimmune disease into a research opportunity. But that’s exactly what Johnson is doing, and honestly, it’s kind of his brand.

The Disease and the Connection

Autoimmune gastritis isn’t some rare condition Johnson randomly developed. According to the Mayo Clinic, it affects up to 2% of the U.S. population and can lead to ulcers and increased stomach cancer risk. Symptoms include burning pain, nausea, and that awkward feeling of fullness after barely eating anything.

What’s interesting is that Johnson thinks he knows why he has this now. He was diagnosed with autoimmune thyroid disease at age 21, decades before he started his now-famous longevity protocol. The connection? “The thyroid and the stomach are closely linked in autoimmunity,” Johnson explained. When one gets attacked by your immune system, the other often follows. There’s even a clinical term for it: thyrogastric syndrome, first described in the 1960s.

So this isn’t entirely unexpected for Johnson. It’s been brewing for 27 years.

The Biohacker’s Response

Instead of accepting the diagnosis and moving on, Johnson did what any wealthy entrepreneur obsessed with entertainment value and self-optimization would do: he decided to solve it.

A few days ago, Johnson had what he calls “a massive blood draw.” His team is now sequencing 1 million of his immune cells. The logic is straightforward: your body has trillions of immune cells that function like soldiers, each carrying a specific key designed to kill a specific threat. Some of Johnson’s soldiers have gone rogue and are attacking his stomach instead of actual pathogens.

By identifying these rebel cells through sequencing, Johnson believes he and his team can “design specific solutions” to prevent them from spreading. And here’s the part that matters beyond just Johnson’s vanity project: he says he’ll make the findings reproducible to help millions of people with autoimmune gastritis.

A Pattern of Extreme Longevity Pursuits

This diagnosis fits perfectly into Johnson’s documented obsession with living longer. He’s already spent millions on supplements, AI monitoring, and even blood plasma transfusions from his own teenage son. His efforts were chronicled in the 2025 Netflix documentary “Don’t Die: The Man Who Wants to Live Forever,” which sounds like satire but apparently isn’t.

Johnson has been vocal about wanting to live for over a century. “I really want to have multiple lifetimes with my son,” he said in the Netflix doc. “One hundred years is not going to be enough.” This new autoimmune disease diagnosis is just another obstacle to treat like a startup problem that needs solving.

The Bigger Picture

Johnson is also a significant supporter of President Trump and Health and Human Services Secretary Robert F. Kennedy Jr., championing the “Make America Healthy Again” mantra. He’s become something of a poster child for the burgeoning longevity movement, which is gaining traction in mainstream culture and tech circles.

The question is whether Johnson’s approach to solving his own autoimmune gastritis will actually benefit the millions who have no access to his resources, or if this is ultimately another vanity project dressed up as philanthropy. Either way, you have to admire the audacity: most people would get the diagnosis and adjust their diet. Johnson is out here trying to reprogram his immune system.

It raises an uncomfortable question about wealth and health innovation: when someone like Bryan Johnson gets sick, does he get better faster because he can throw millions at the problem and attract top researchers? And what does that mean for everyone else?

Source: HuffPost